-
New Drug Shows Promise for Treating Rare Brain Tumors
An experimental drug may provide a new treatment option for some patients with rare incurable brain tumors, according to an analysis published in the Journal of Clinical Oncology.
-
Treating Skin Cancer Without Risking Transplanted Kidneys in Organ Recipients
Specific immunosuppressants and immunotherapy are not enough to prevent organ rejection in patients undergoing skin cancer treatment who have also received a kidney transplant, according to a clinical trial published in the Journal of Clinical Oncology.
-
First-year PA Student Awarded National Health Service Corps Scholarship
Lisa Namatame, a first-year Physician Assistant (PA) student, was recently awarded a scholarship from the National Health Service Corps Scholarship Program supported by the U.S. Department of Health and Human Services’ Health Resources and Services Administration.
-
Renowned Pulmonologist and Accomplished Clinical Educator Named Inaugural Director of Center for Bedside Medicine
Brian Garibaldi, MD, MEHP, professor of Medicine and of Physiology at the Johns Hopkins University School of Medicine, has been named the Charles Horace Mayo Professor of Medicine and the inaugural director of the new Center for Bedside Medicine at Northwestern.
-
Cellular Therapy Increases Survival in Recurring B-cell Lymphoma
A two-year follow-up clinical trial found that a personalized cellular therapy treatment for relapsed or refractory B-cell lymphoma demonstrated high safety and improved overall survival in patients, according to findings published in Blood.
-
Outsmarting Chemo-Resistant Ovarian Cancer
Northwestern Medicine scientists have discovered the Achilles heel of chemotherapy-resistant ovarian cancer — its hunger for cholesterol — and how to sneakily use that to destroy it.
-
Engineered Heart Cells May Improve Understanding of Atrial Fibrillation
A multidisciplinary team of investigators have engineered a more accurate model for studying the underlying mechanisms of atrial fibrillation and treatment response, according to findings published in Science Advances.
-
Novel Pathway Explains the Escalation of Fear Responses
Scientists have discovered a neuronal pathway involved in how the brain encodes the transition to high-intensity fear response behaviors required for survival, according to a study published in Nature.
-
Calming Neurotransmitter Can Also Be Excitatory
A neurotransmitter previously thought to only calm neurons may also play a role in waking them up, according to a study published in the journal PLOS Biology, a discovery which upends conventional theories of how the neurotransmitter works in the brain.
-
Analysis of K99/R00 Pipeline Illustrates Systematic Disadvantages
An analysis of NIH training grants has illustrated systematic disadvantages among the trainees who receive the awards.
-
Study Shows Tiny ‘Twisters’ Move Cytoplasm Within Cells
Investigators at Northwestern Medicine and the Flatiron Institute have characterized how developing cells reorganize their cytoplasm as part of their growth, according to a study published in Nature Physics, a discovery which furthers the field’s understanding of basic cellular processes at the earliest stages of development.
-
Neuronal Diversity Impacts the Brain’s Information Processing
Northwestern Medicine investigators have revealed new insights into the impact of neuronal structural diversity on neural computation, the basis of brain function, according to a recent study published in the Proceedings of the National Academy of Sciences.
-
Rethinking the Burden of Cancer Treatments’ Side Effects
Even mild and moderate side effects can contribute to patients with cancer discontinuing their treatment, according to an analysis recently published in the Journal of Clinical Oncology.
-
Genes May Predict Treatment Resistance in Prostate Cancer
Increased expression of specific genes in prostate cancer patients may predict whether or not the cancer will respond well to hormone therapy, according to a new study published in Nature Communications.
-
Immune Genes Are Altered in Alzheimer’s Patients’ Blood
A new study has found the immune system in the blood of Alzheimer’s patients is epigenetically altered, and many of these altered genes are the same ones that increase an individual’s risk for Alzheimer’s.
-
Shedding Light on the Synaptic Complexities of Vision
An individual retinal cell can output more than one unique signal, according to a Northwestern Medicine study published in Nature Communications, a finding which sheds new light on the complexities of how vision functions in mammals.
-
Human Longevity Lab Will Study Methods to Slow or Reverse Aging
Northwestern Medicine has launched the Human Longevity Laboratory, a longitudinal, cross-sectional study that will investigate the relationship between chronological age and biological age and validate interventions that may reverse or slow down the processes of aging.
-
How Research is Changing the Conversation about Obesity
In the last several years, anti-obesity medications have made an impression through wide media coverage and interest in their effectiveness. Feinberg investigators have been leading research on these drugs for the treatment of obesity and advocating for access to these medications for the patients who need it most.
-
Feinberg Faculty Inducted into American Society for Clinical Investigation
Four Feinberg faculty have been inducted into the American Society for Clinical Investigation (ASCI) and three additional Feinberg faculty have been honored with the ASCI Young Physician-Scientist Award.
-
Wakschlag Honored With 2024 Paula H. Stern Award
Lauren Wakschlag, PhD, professor of Medical Social Sciences, Pediatrics and Psychiatry and Behavioral Sciences, has been awarded the Paula H. Stern Award for Outstanding Women in Science and Medicine by the Northwestern Medical Women Faculty Organization.
